Our findings of a reduction in all‐cause mortality with insulin pump use are consistent with results from the Swedish National Diabetes Register involving 2441 patients, which showed reduced all‐cause mortality in pump users compared to MDI (HR = 0.73 [95% CI 0.58–0.92], p = 0.007).16 This evidence concerns the gene INS and diabetes mellitus.